Expert Insight

Expert Insight

The Manufacturing Era of Cell and Gene Therapy

24 July 2026

Expert Insight

What Capacity Constraints Mean for CDMO Selection

22 July 2026

Expert Insight

3 Things Biotechs Need Before Going Public in 2026 

14 July 2026

Expert Insight

CMC Pharmaceuticals’ Mike Radomsky on the Mistakes That Kill Drug Programs

3 July 2026

Expert Insight

What the Alcami Tjoapack Deal Means for Your Supply Chain 

1 July 2026

Expert Insight

CDMO Selection for Small Biotech: Amit Jain on Avoiding Costly Transfers

24 June 2026

Expert Insight

FDA Scrutiny Is Exposing a CDMO Quality Oversight Crisis

19 June 2026

Expert Insight

Proteomics Gains Ground Across the Pharmaceutical Value Chain

17 June 2026

Content

Leucid Bio: How Biology-First Thinking Should Drive Your CDMO Strategy

5 June 2026

Expert Insight

AI Governance in Pharma: FDA-EMA Principles and What Comes Next

3 June 2026